Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) Short Interest Down 44.7% in June

Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) was the target of a large decrease in short interest in the month of June. As of June 15th, there was short interest totaling 7,733 shares, a decrease of 44.7% from the May 31st total of 13,976 shares. Approximately 1.1% of the shares of the company are sold short. Based on an average trading volume of 5,224 shares, the short-interest ratio is presently 1.5 days.

Institutional Investors Weigh In On Virtus LifeSci Biotech Products ETF

A number of hedge funds have recently added to or reduced their stakes in the stock. Prime Capital Investment Advisors LLC purchased a new position in Virtus LifeSci Biotech Products ETF during the fourth quarter worth $1,896,000. Flow Traders U.S. LLC purchased a new position in shares of Virtus LifeSci Biotech Products ETF during the 2nd quarter worth about $431,000. Finally, Comprehensive Financial Planning Inc. PA bought a new position in Virtus LifeSci Biotech Products ETF during the 4th quarter valued at about $557,000.

Virtus LifeSci Biotech Products ETF Stock Performance

Shares of BBP stock traded up $3.06 during trading hours on Thursday, reaching $99.08. The company had a trading volume of 6,725 shares, compared to its average volume of 7,809. The business has a fifty day moving average price of $87.95 and a 200-day moving average price of $84.33. Virtus LifeSci Biotech Products ETF has a one year low of $58.97 and a one year high of $99.08.

About Virtus LifeSci Biotech Products ETF

The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is managed by Virtus.